Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop the weight management program, which is combined with
healthy diet, proper physical exercise, and behavior modification, related to patient's
quality of life. The patients groups are in routine practice with 5-20 mg olanzapine. The
study results may be utilized for patients who have gained weight on olanzapine and also
other antipsychotic drugs.